National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

@article{Ferguson2000NationalIO,
  title={National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)},
  author={J. H. Ferguson},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2000},
  volume={39 2},
  pages={
          182-93
        }
}
  • J. H. Ferguson
  • Published 2000
  • Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
    • Attention-deficit/hyperactivity disorder (ADHD) is a commonly diagnosed behavioral disorder of childhood that represents a costly major public health problem. Despite progress, ADHD and its treatment have remained controversial, especially the use of psychostimulants for both short- and long-term treatment. Although an independent diagnostic test for ADHD does not exist, there is evidence supporting the validity of the disorder. Studies (primarily short-term, approximately 3 months), including… CONTINUE READING
    View on PubMed
    doi.org
    282 Citations
    Highly Influential Citations
    6
    Background Citations
    22
    Methods Citations
    5
    282 Citations
    Citation Type

    Citation Type

    AN UPDATE ON THE DIAGNOSIS AND TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDREN
    • 82
    The Role of Neuropsychological Assessment in the Functional Outcomes of Children with ADHD
    • 35
    The National Institutes of Health Attention-Deficit/Hyperactivity Disorder Consensus Statement: Implications for Practitioners and Scientists
    • 8
    Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults
    • 52
    Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults
    • 19
    Is there a future for restricted elimination diets in ADHD clinical practice?
    • 7
    • PDF
    Lessons from the Literature
    • 2
    Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    • 20
    • PDF
    Common ground in Attention Deficit Hyperactivity Disorder (ADHD) and Borderline Personality Disorder (BPD)–review of recent findings
    • 50
    Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches
    • 34

    References

    SHOWING 1-10 OF 91 REFERENCES
    National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.
    • 237
    NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale.
    • 283
    Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.
    • 789
    Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children.
    • 342
    Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    • 1,025
    • PDF
    Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.
    • 565
    Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder.
    • 313
    Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.
    • 885
    A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.
    • 707
    Attention‐Deficit Hyperactivity Disorder and Substance Abuse: Relationships and Implications for Treatment
    • 108